Showing results (2251-2260 of 2,613) with videos related to

Sort By:
Pageof 262
Metabolites|April 30, 2021
Metabolite Profile of Treatment-Naive Metabolic Syndrome Subjects in Relation to Cardiovascular Disease RiskMoritz V Warmbrunn, Annefleur M Koopen, Nicolien C de Clercq, et al.
British Journal of Cancer|July 28, 2023
Incidence of inguinofemoral lymph node metastases at the first local recurrence of vulvar cancer: a Dutch nationwide studyNoortje Pleunis, Anne-Floor W Pouwer, Maaike H M Oonk, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 8, 2026
Immune checkpoint inhibitor-induced eosinophilic fasciitis: A pharmacovigilance and EADV Task force studyTristan V M Bruijn, Alexandre O Gérard, Maëlys Labat, et al.
Oncotarget|March 26, 2016
Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17Quirijn R J G Tummers, Charlotte E S Hoogstins, Katja N Gaarenstroom, et al.
Lancet (London, England)|April 16, 2016
Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trialVincent Ribrag, Serge Koscielny, Jacques Bosq, et al.
Cells|June 2, 2021
Proteoglycan 4 Modulates Osteogenic Smooth Muscle Cell Differentiation during Vascular Remodeling and Intimal CalcificationTill Seime, Asim Cengiz Akbulut, Moritz Lindquist Liljeqvist, et al.
Clinical Chemistry and Laboratory Medicine|February 16, 2022
Report from the HarmoSter study: impact of calibration on comparability of LC-MS/MS measurement of circulating cortisol, 17OH-progesterone and aldosteroneFlaminia Fanelli, Marco Cantù, Anastasia Temchenko, et al.
Rheumatology (Oxford, England)|September 19, 2020
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndromeMaria Juarez, Nieves Diaz, Geoffrey I Johnston, et al.
Journal for Immunotherapy of Cancer|January 18, 2022
CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumorsChantal L Duurland, Saskia J Santegoets, Ziena Abdulrahman, et al.
Journal of Medicinal Chemistry|April 28, 2023
Discovery of an Oral, Beyond-Rule-of-Five Mcl-1 Protein-Protein Interaction Modulator with the Potential of Treating Hematological MalignanciesFedor Romanov-Michailidis, Chien-Chi Hsiao, Lorenz M Urner, et al.
Pageof 262